Viwit Pharm Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VIWIT PHARM, and what generic and branded alternatives to VIWIT PHARM drugs are available?
VIWIT PHARM has five approved drugs.
Summary for Viwit Pharm
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Viwit Pharm
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Viwit Pharm | NITROGLYCERIN | nitroglycerin | TABLET;SUBLINGUAL | 218583-003 | Oct 15, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Viwit Pharm | NITROGLYCERIN | nitroglycerin | TABLET;SUBLINGUAL | 218583-002 | Oct 15, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Viwit Pharm | LEVETIRACETAM | levetiracetam | TABLET;ORAL | 078869-002 | Mar 13, 2009 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Viwit Pharm | NITROGLYCERIN | nitroglycerin | TABLET;SUBLINGUAL | 218583-001 | Oct 15, 2024 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Viwit Pharm | LEVETIRACETAM | levetiracetam | TABLET;ORAL | 078869-003 | Mar 13, 2009 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Viwit Pharm | PROCHLORPERAZINE EDISYLATE | prochlorperazine edisylate | INJECTABLE;INJECTION | 213626-001 | Sep 28, 2021 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
